Prof Robyn Guymer to head up new 2RT study for iAMD

Adelaide-based Nova Eye Medical says it has navigated a time-consuming and complex series of conversations with the US Food and Drug Administration (FDA) to pave a clear approval pathway for its pioneering 2RT laser system for selected intermediate age-related macular degeneration (iAMD) patients. Read more

People on the move – May 2022

Welcome to People on the move –  May 2022, Insight’s monthly bulletin to keep the Australian ophthalmic sector updated on new appointments and personnel changes. Read more

Bausch + Lomb eyes AU$1.2 billion in IPO

Ophthalmic giant Bausch + Lomb (B+L), which is being spun-off from its parent as a pure-play eye health company, has filed to raise up to US$840 million (AU$1.2 billion) in an initial public offering (IPO). Read more

© All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

JOIN OUR NEWSLETTER

JOIN OUR NEWSLETTER
Close